FDA product code QJE: Muscular Dystrophy Newborn Screening Test

QJE is the FDA product code for muscular dystrophy newborn screening test. It is a Class II device, regulated under 21 CFR 862.1506 and reviewed by the Clinical Chemistry panel. Devices under QJE reach the market by 510(k); FDA lists no cleared 510(k)s for it. 1 De Novo request was granted under it.

Definition

A muscular dystrophy newborn screening test is intended to measure creatine kinase levels obtained from dried blood spot specimens on filter paper from newborns as an aid in screening newborns for muscular dystrophy.

Classification

FieldValue
Device nameMuscular Dystrophy Newborn Screening Test
Device classClass II
Regulation21 CFR 862.1506
Review panelCH — Clinical Chemistry
Medical specialtyClinical Chemistry
Premarket route510(k)

Recalls for QJE devices

FDA recall records list no recalls for product code QJE.

Frequently asked questions

What is FDA product code QJE?

QJE is the FDA product code for muscular dystrophy newborn screening test. It is a Class II device, regulated under 21 CFR 862.1506 and reviewed by the Clinical Chemistry panel.

What device class is QJE?

Class II, regulation 21 CFR 862.1506. Typical premarket route: 510(k).

Next steps

Compiled by Caduvo from public U.S. FDA records. Applicant names are shown as FDA records them. Review days run from FDA receipt to decision. Not reviewed or endorsed by FDA. Not regulatory advice. Report an error. Data and corrections policy.

All Clinical Chemistry product codes · FDA product code lookup · 510(k) database search · 510(k) review times